Neuronasal Employee Directory

Neuronasal corporate office is located in 2465 Citation Ct, Wexford, Pennsylvania, 15090, United States and has 11-50 employees.

Neuronasal Global Presence

globalPresence illustration
North America1-10

Neuronasal CEO

TB
United States flag for contact location.
Thomas BradshawChief Executive Officer
PhonePhoneEmailEmail
See Profile

Key Employees of Neuronasal

  • MK
    United States flag for contact location.
    Michael Kaufma...

    Commercialization Vice President, Business Develop...

    PhonePhoneEmailEmail
  • PhonePhoneEmailEmail
  • PhonePhoneEmailEmail
  • PhonePhoneEmailEmail
  • PhonePhoneEmailEmail
  • PhonePhoneEmailEmail

Index of contact profiles from Neuronasal

Hundreds of professionals searching for Neuronasal have connected with key decision-makers. Join them?
Contact Name
Contact Info
Job Title
HQ Location
12

Former Employees at Neuronasal

Explore people who held key positions, contributed to Neuronasal's success, and advanced their careers.

  1. Chief Medical Officer at Filana Therapeutics

    Worked as Advisor

    at Neuronasal (2017-2026)

    email Joseph Hulihan Email direct Joseph Hulihan Direct

Explore More

People from Similar Companies in the Manufacturing Industry Located in Pennsylvania, United States

Frequently Asked Questions Regarding Neuronasal Employees

How many employees does Neuronasal have?
Neuronasal has 11-50 employees
Who is the CEO of Neuronasal?
Neuronasal’s CEO is Thomas Bradshaw
Who are Neuronasal key employees?
Some of Neuronasal key employees are Michael Kaufman
Where is Neuronasal located?
Neuronasal’s headquarters are located at 2465 Citation Ct, Wexford, Pennsylvania, 15090, United States
How do I contact Neuronasal?
Neuronasal Contact Info: Phone number: (617) 714-3075 Website: www.neuronasal.com
What does Neuronasal do?

Neuronasal is focused on addressing critical medical needs through innovative treatments for Parkinson's Disease and Mild Traumatic Brain Injury. The company has developed a novel intranasal delivery method for the FDA-approved drug n-acetylcysteine (NAC), which has shown efficacy in clinical trials. Their unique approach allows for targeted drug d... elivery to specific brain regions, overcoming limitations of traditional dosing methods. Neuronasal aims to improve patient outcomes with its patented technology and is currently conducting Phase 1 clinical research funded by a STTR NIH/NIA grant.Read More

Is Neuronasal a public company?
Neuronasal is private company therefore does not currently have an official ticker symbol
See more information about Neuronasal Employees

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.